4.7 Article

The histone methyltransferase Ezh2 restrains macrophage inflammatory responses

期刊

FASEB JOURNAL
卷 35, 期 10, 页码 -

出版社

WILEY
DOI: 10.1096/fj.202100044RRR

关键词

EZHZ; inflammation; lung; macrophage; neutrophil

资金

  1. Medical Research Council Canada (MRC) [MR/N002024/1]
  2. RCUK \ Medical Research Council (MRC) [MRNO2995X/1]
  3. Wellcome Trust (Wellcome) [107849/Z/15/Z, 107851/Z/15/Z]
  4. RCUK \ Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L000954/1, BB/K003097/1]
  5. BBSRC [BB/L000954/1, BB/K003097/1] Funding Source: UKRI
  6. Wellcome Trust [107851/Z/15/Z, 107849/Z/15/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

Robust inflammatory responses are crucial for survival after respiratory infections, and Epigenetic factors are increasingly being recognized as important determinants of immune responses. EZH2 acts differently in macrophages and neutrophils, affecting inflammatory responses and chemotaxis. Targeting EZH2 may have implications for mucosal immunity and conditions driven by pulmonary neutrophil influx.
Robust inflammatory responses are critical to survival following respiratory infection, with current attention focused on the clinical consequences of the Coronavirus pandemic. Epigenetic factors are increasingly recognized as important determinants of immune responses, and EZH2 is a prominent target due to the availability of highly specific and efficacious antagonists. However, very little is known about the role of EZH2 in the myeloid lineage. Here, we show EZH2 acts in macrophages to limit inflammatory responses to activation, and in neutrophils for chemotaxis. Selective genetic deletion in macrophages results in a remarkable gain in protection from infection with the prevalent lung pathogen, pneumococcus. In contrast, neutrophils lacking EZH2 showed impaired mobility in response to chemotactic signals, and resulted in increased susceptibility to pneumococcus. In summary, EZH2 shows complex, and divergent roles in different myeloid lineages, likely contributing to the earlier conflicting reports. Compounds targeting EZH2 are likely to impair mucosal immunity; however, they may prove useful for conditions driven by pulmonary neutrophil influx, such as adult respiratory distress syndrome.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据